|
Volumn 9, Issue 8, 2002, Pages 869-877
|
Docetaxel (taxotere) in the treatment of non-small cell lung cancer
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
BACCATIN III;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
IRINOTECAN;
NAVELBINE;
OPIATE;
PACLITAXEL;
TUBULIN;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
ASTHENIA;
BONE MARROW SUPPRESSION;
CELL CYCLE G2 PHASE;
CELL CYCLE S PHASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG BINDING;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG RESPONSE;
DRUG SYNTHESIS;
FATIGUE;
FEBRILE NEUTROPENIA;
FLUID RETENTION;
HUMAN;
LUNG NON SMALL CELL CANCER;
METAPHASE;
MICROTUBULE;
MITOSIS INHIBITION;
NAUSEA AND VOMITING;
NEUTROPENIA;
PROTEIN POLYMERIZATION;
RADIOSENSITIZATION;
REVIEW;
STOMATITIS;
SURVIVAL TIME;
TAXUS;
THROMBOCYTOPENIA;
TAXUS BACCATA;
|
EID: 0036250015
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867024606812 Document Type: Review |
Times cited : (21)
|
References (89)
|